LTS SMART
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LTS SMART Trademark

Serial Number: 88179774 • Registration: 5993702

LTS SMART is a trademark filed by LTS Lohmann Therapie-Systeme AG on November 2, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 20 (Furniture), Class 21 (Housewares). The application is currently registered and active.

Owner Contact Info

LTS Lohmann Therapie-Systeme AG (10 trademarks)

Lohmannstrasse 2
Andernach 56626 , DE

Entity Type: 99

Trademark Details

Filing Date

November 2, 2018

Registration Date

February 25, 2020

Published for Opposition

December 10, 2019

Goods & Services

Pharmaceutical and veterinary preparations, namely, injectable pharmaceutical and veterinary preparations for the prevention and treatment of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists by intracutaneous, intradermal, subcutaneous, intramuscular, intravenous and intra-articular injection, the aforesaid injection preparations being for needle-free injection or for injection by means of needle or cannula systems; injectable pharmaceutical and veterinary preparation therapeutic or prophylactic ingredients or diagnostic preparations, namely, pharmaceutical and therapeutic preparations for use with pets, laboratory animals, wild animals, zoo animals and livestock, including aquaculture, for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; preparations for destroying vermin; fungicides; herbicides; pharmaceuticals for use in the gastrointestinal tract, subcutaneous use and for oral use for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; medicines for administration in the form of plasters and wafers containing active ingredients, namely, medicines for the treatment of gastrointestinal diseases; medical plasters containing active ingredients for transdermal administration of active ingredients, medical plasters containing active ingredients for topical processing of active ingredients, and for manufacturing active ingredient-free laminates

Chemicals used in industry; chemicals used in science; injection preparations for needle-free injection, for injection by means of needles, or injection by cannula systems, namely, chemicals for use in agriculture, horticulture, and in forestry, except fungicides, herbicides, insecticides and parasiticides, the aforesaid products and injection preparations being for livestock farming or animal breeding, including aquaculture

Medical services; veterinary services; pharmaceutical consultation; hygienic care for human beings; beauty care for human beings; animal healthcare services, namely, veterinary services; animal beautician services, namely, pet grooming services; agriculture services, namely, compost spreading; horticultural services; forestry, namely, insecticide spraying for forestry; all of the aforesaid in the field of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae; medical consultations for patients and qualified personnel, in particular doctors, in relation to medicine delivery systems and instruments, in particular comprising microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; preparation and administration of medicines, including by means of plasters for use on the skin, namely, preparation of prescriptions by pharmacists

Surgical, medical, dental and veterinary instruments and apparatus, namely, instruments and apparatus for injecting substances, in particular infusion and injection device for administering drugs, needle-free, via needles, by cannulae, or through an injection systems comprised primarily of a needle-free injection device, ampoules, storage bottles and accessories for injection devices; dropper bottle for administering medication, sold empty; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies for use in dermal, transdermal, mucosal and transmucosal sampling of bodily fluids; medical devices and instruments for administering pharmaceuticals and biotechnological molecules using needle-like microstructures, plaster needles for medical purposes for use on the skin; injection device for pharmaceuticals, namely, medical injection device for administering drugs; parts for the aforesaid goods, in particular microneedles and/or microneedle assemblies for use in administering pharmaceuticals and biotechnological molecules

Ampoules for medication sold empty

Nonmetal and non-paper containers for storage or transport of injection devices consisting of needle-free injection systems or systems for injection using needles or cannulae, medical products

Scientific and technological services and research, namely, development of pharmaceuticals veterinary preparations and medicines, up to the production stage; conducting of analytical testing of pharmaceuticals and veterinary preparations; new product design with respect to health care products in the nature of pharmaceutical and veterinary preparations; industrial analysis and research, namely, testing, analysis and evaluation of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae and the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules of others to assure compliance with industry standards; design and development of computer hardware and software

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 25, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 4, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 4, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 4, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 4, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 31, 2019 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2019 CRFA
ASSIGNED TO LIE
Oct 28, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 22, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 12, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 12, 2019 GNSL
SUSPENSION LETTER WRITTEN
Aug 12, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2019 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2018 NWOS
NEW APPLICATION ENTERED
Nov 6, 2018 NWAP